Thank you to @theABTA for their generous support for my research @TyMillerLab and honoured to be a part of such a fantastic group of future physicians!
🧠 Meet the 2025 ABTA Medical Student Summer Fellows!
11 med students will spend their summer in brain tumor research labs, gaining hands-on experience in neuro-oncology.
Learn more: https://t.co/FhIOCDsuUg
Congrats to the next gen of brain tumor researchers! 🎉
Celebrating two summer fellowships today with ice cream @ Mitchells! Congrats to Kaylie for being awarded the CanSUR fellowship for undergraduates and @CWRUSOM student Alex Wang the @caseccc Medical Training Award! Both awards will support their work in the lab this summer 🔬
So impressed with Cleveland Clinic. We are keeping our trials open and maintaining our sights on true north. I’m sad to hear of all the research and trials in the US that are gone because of the massive cuts to research. many deaths will be the result-this will affect us all
Proud to share our latest work in @nature, co-led by @chadi_elfarran, @CouturierMDPhD & @BradEBernstein! We developed a new framework to understand immunomodulatory myeloid cells in #glioma & lay a foundation to develop more effective immunotherapies🧵 https://t.co/OHaqovnefp
Huge believer in this concept! Let’s prioritize quality over quantity in neurosurgery 🧠🔬@TheJNS @MGHNeurosurg @MGHNSResidency https://t.co/3mQLUYrxzX
Also a Proud PI moment - it was the @TyMillerLab's month to present and @Shawn_T_Ho, @alexfwang, and Alex Crane gave awesome presentations laying out their new project ideas for the lab 💪
.@TyMillerLab lab meeting on how we can best use AI tools / AI-agents in a responsible way to make us a more efficient lab! Started with an overview of this paper from @marinkazitnik
I am honored and humbled to be appointed as the Paul and Betsy Shiverick Professor of Immuno-Oncology. I’m very grateful for generosity and the vision of Paul and Betsy to establish this Professorship &feel incredibly fortunate to be the inaugural chairholder @caseccc & @CWRUSOM!
JUST IN: @Merck pembrolizumab Met Primary Endpoint of Event-Free Survival as Perioperative Treatment Regimen in Patients With Resected, Locally Advanced Head and Neck Squamous Cell Carcinoma!
Press release below https://t.co/miaet58xOx
BREAKING: The #FDA has approved vorasidenib for the treatment of patients 12 and older with IDH-mutant, grade 2 astrocytoma or oligodendroglioma, based on data from the pivotal phase 3 INDIGO trial.
https://t.co/DWgbn3O51v
See here how brain tumor cells dynamically recruit neurons during cancer progression with rabies-based retrograde tracing! #CancerNeuroscience#FluorescenceFriday
Truly game changing work developing CAR-T for brain tumor patients. So incredibly proud of the work of @MarcelaMaus@BryanDChoi@WTCNeuroscience providing incredible promise for our brain tumor patients around the world. Establishing an incredible neuroimmunology program for brain tumor patients all over the world. #cantstopwontstop until there is a cure. https://t.co/WH0SWidjT7 @MGHCancerCenter @MassGenBrigham@MGBneurosurgery
Introducing our new member Ethan Wetzel, graduate of @UCLA and incoming first-year student @harvardmed whose interests include neuro-oncology and advancing health equity!
Introducing our new member @alexfwang, graduate of @UCLA and incoming first-year student @CWRUSOM whose interests include immunotherapy for GBM, language disorders, and neurorehabilitation!
S/o to our CNRG Team Lead @ShahaanRazak for pioneering this staple in Neurosurgery, hosting the 3rd Annual Global Hackathon! Can they top 46 countries represented from last year?
Couldn’t do it without Super Mentors like
@BrianNahed@DoctorQMd#missionbrainhack24